Illinois AG warns against misleading GLP-1 drug sales, urging consumers to only buy from reliable sources and use ...

Trump could keep Biden’s commitment to have Medicare pay for weight loss drugs such as Ozempic and Wegovy. But would ...

On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a declaratory order determining that the shortage of diabetes and ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Patients waiting for NHS weight loss jabs are buying potentially unsafe jabs online or from gyms and beauty salons ...

Glaswegian cosmetic practitioner Awfa Paulina said weight-loss drugs can be 'effective tools', but that no guarantees can be ...

On its way out the door, the Biden administration is proposing that Medicare and Medicaid cover Ozempic and other GLP-1 drugs ...

Blue Cross & Blue Shield of Rhode Island reported an operating loss of $30 million through the first three quarters of 2024. A continuing surge in the volume and cost of medical services – which ...

Currax Pharmaceuticals is kicking off the new year with a new direct-to-consumer campaign for its weight loss medication ...

Eli Lilly has asked to join in opposing a lawsuit brought by compounding pharmacies against the U.S. Food and Drug ...

The MHRA warns against buying weight-loss medicines illegally, emphasizing health risks and the need for prescriptions from ...

In 2024, the state experienced developments in healthcare that will play out in 2025. Ten of them should be on your radar.